8 results
P01-166 - Transitioning onto OROS MPH is Associated with Improved Functioning and Quality of Life in Adolescents with ADHD
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E372
-
- Article
-
- You have access
- Export citation
P03-347 Transitioning Onto OROS MPH is Associated with Improved Functioning and Quality of Life in Children and Adolescents with ADHD
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E953
-
- Article
-
- You have access
- Export citation
YPSP01-02 - Effectiveness, Quality Of Life And Changes In Burden Of Disease In Children And Adolescents With Adhd Transitioning To Oros Mph
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1682
-
- Article
-
- You have access
- Export citation
PW01-63 - Functionality And Quality Of Life In Children And Adolescents With Adhd Transitioning To Oros Mph - Correlations Of Outcomes
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1462
-
- Article
-
- You have access
- Export citation
P0321 - Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS®-MPH) - results from an open-label naturalistic study
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation
Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS®-MPH) improves quality of life of patients with adhd -a naturalistic study
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S253
-
- Article
-
- You have access
- Export citation
P0282 - Treatment with OROS®-Methylphenidate in adolescents is associated with an improvement in functioning and quality of life - A post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S383
-
- Article
-
- You have access
- Export citation
P0320 - OROS®-MPH in adolescents with ADHD transitioning from Atomoxetine or ER-MPH (medikinet retard®) - a post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation